186 related articles for article (PubMed ID: 18408253)
1. Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients.
Goodson NJ; Brookhart AM; Symmons DP; Silman AJ; Solomon DH
Ann Rheum Dis; 2009 Mar; 68(3):367-72. PubMed ID: 18408253
[TBL] [Abstract][Full Text] [Related]
2. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort.
Goodson NJ; Symmons DP; Scott DG; Bunn D; Lunt M; Silman AJ
Arthritis Rheum; 2005 Aug; 52(8):2293-9. PubMed ID: 16052597
[TBL] [Abstract][Full Text] [Related]
3. Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis.
Franklin J; Farragher TM; Lunt M; Camacho EM; Bunn D; Marshall T; Symmons DP
Ann Rheum Dis; 2010 Sep; 69(9):1660-4. PubMed ID: 20498206
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR).
Mirjafari H; Welsh P; Verstappen SM; Wilson P; Marshall T; Edlin H; Bunn D; Chipping J; Lunt M; Symmons DP; Sattar N; Bruce IN
Ann Rheum Dis; 2014 Apr; 73(4):684-90. PubMed ID: 23511225
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease and non-steroidal anti-inflammatory drug prescribing in the midst of evolving guidelines.
Pham TT; Miller MJ; Harrison DL; Lloyd AE; Crosby KM; Johnson JL
J Eval Clin Pract; 2013 Dec; 19(6):1026-34. PubMed ID: 23163341
[TBL] [Abstract][Full Text] [Related]
6. Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Farragher TM; Lunt M; Bunn DK; Silman AJ; Symmons DP
Ann Rheum Dis; 2007 Apr; 66(4):486-92. PubMed ID: 17090565
[TBL] [Abstract][Full Text] [Related]
7. Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register.
Gwinnutt JM; Symmons DPM; MacGregor AJ; Chipping JR; Marshall T; Lunt M; Verstappen SMM
Ann Rheum Dis; 2018 Jun; 77(6):848-854. PubMed ID: 29475855
[TBL] [Abstract][Full Text] [Related]
8. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.
Goodson NJ; Wiles NJ; Lunt M; Barrett EM; Silman AJ; Symmons DP
Arthritis Rheum; 2002 Aug; 46(8):2010-9. PubMed ID: 12209502
[TBL] [Abstract][Full Text] [Related]
9. Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study.
Mirjafari H; Farragher TM; Verstappen SM; Yates A; Bunn D; Marshall T; Lunt M; Symmons DP; Bruce IN
Arthritis Res Ther; 2011; 13(5):R159. PubMed ID: 21959060
[TBL] [Abstract][Full Text] [Related]
10. The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis.
Naz SM; Farragher TM; Bunn DK; Symmons DP; Bruce IN
Arthritis Rheum; 2008 Apr; 58(4):985-9. PubMed ID: 18383358
[TBL] [Abstract][Full Text] [Related]
11. Association of a rheumatoid arthritis susceptibility variant at the CCL21 locus with premature mortality in inflammatory polyarthritis patients.
Farragher TM; Plant D; Flynn E; Eyre S; Bunn D; Thomson W; Symmons D; Barton A
Arthritis Care Res (Hoboken); 2010 May; 62(5):676-82. PubMed ID: 20461788
[TBL] [Abstract][Full Text] [Related]
12. Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis.
Lin TC; Solomon DH; Tedeschi SK; Yoshida K; Kao Yang YH
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079568
[TBL] [Abstract][Full Text] [Related]
13. Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register.
Scirè CA; Lunt M; Marshall T; Symmons DP; Verstappen SM
Ann Rheum Dis; 2014 Sep; 73(9):1677-82. PubMed ID: 23749581
[TBL] [Abstract][Full Text] [Related]
14. Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study.
Johnson AG; Simons LA; Simons J; Friedlander Y; McCallum J
Br J Clin Pharmacol; 1993 May; 35(5):455-9. PubMed ID: 8512757
[TBL] [Abstract][Full Text] [Related]
15. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
[TBL] [Abstract][Full Text] [Related]
16. Comparative Risks of Nonsteroidal Anti-inflammatory Drugs on Cardiovascular Diseases: A Population-Based Cohort Study.
Wan EYF; Yu EYT; Chan L; Mok AHY; Wang Y; Chan EWY; Wong ICK; Lam CLK
J Clin Pharmacol; 2023 Jan; 63(1):126-134. PubMed ID: 36063443
[TBL] [Abstract][Full Text] [Related]
17. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts.
Wong AY; MacKenna B; Morton CE; Schultze A; Walker AJ; Bhaskaran K; Brown JP; Rentsch CT; Williamson E; Drysdale H; Croker R; Bacon S; Hulme W; Bates C; Curtis HJ; Mehrkar A; Evans D; Inglesby P; Cockburn J; McDonald HI; Tomlinson L; Mathur R; Wing K; Forbes H; Eggo RM; Parry J; Hester F; Harper S; Evans SJ; Smeeth L; Douglas IJ; Goldacre B;
Ann Rheum Dis; 2021 Jul; 80(7):943-951. PubMed ID: 33478953
[TBL] [Abstract][Full Text] [Related]
18. Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009-2010.
Castelli G; Petrone A; Xiang J; Shrader C; King D
Am J Cardiovasc Drugs; 2017 Jun; 17(3):243-249. PubMed ID: 28063129
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.
Layton D; Souverein PC; Heerdink ER; Shakir SA; Egberts AC
Drug Saf; 2008; 31(2):143-58. PubMed ID: 18217790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
